Assessment of focused multivector ultraviolet disinfection withshadowless delivery using 5-point multisided sampling ofpatientcare equipment without manual-chemical disinfection - 30/03/19
, Thomas J. Walsh, MD, PhD b, Vidmantas Petraitis, MD b, Wladyslaw Kowalski, PhD cRésumé |
Background |
The aim of this study was to evaluate the performance of a focused multivector ultraviolet (FMUV) system employing shadowless delivery with a 90-second disinfection cycle for patient care equipment inside and outside the operating room (OR) suite without manual-chemical disinfection.
Methods |
A 5-point multisided sampling protocol was utilized to measure the microbial burden on objects inside and outside the OR environment in a 3-phase nonrandomized observational study. Surface sampling was performed pre- and postdisinfection in between cases (IBCs) to assess the performance of manual-chemical disinfection. FMUV system performance was separately assessed pre- and postdisinfection before the first case and IBCs. Additionally, visibly clean high-touch objects were sampled outside the OR, and the microbial burden reductions after FMUV disinfection were quantified without manual-chemical disinfection.
Results |
Manual-chemical disinfection reduced the active microbial burden on sampled objects IBCs by 52.8%-90.9% (P < .05). FMUV reduced the active microbial burden by 92%-97.7% (P < .0001) before the firstcase and IBCs combined, and 96.3%-99.6% (P < .0001) on objects outside the OR without chemical disinfection.
Conclusions |
Five-point multisided sampling proved effective for assessing disinfection performance on all exterior sides of equipment. FMUV produced significant overall reductions of the microbial burden on patient care equipment in all study phases and independent of manual cleaning and chemical disinfection.
Le texte complet de cet article est disponible en PDF.Key Words : Environmental disinfection, Surface sampling techniques, Disinfectants, Manual cleaning, Infection prevention, Ultraviolet germicidal irradiation
Plan
| Funding/support: This study was supported by Northwell Ventures. |
|
| PurpleSun Inc received grant support from Health 2.0 and New York City Economic Development Corporation. |
|
| Conflicts of interest: PurpleSun is a portfolio company of Northwell Ventures. |
|
| T.J.W. and V.P. are paid advisors to PurpleSun, and the fees will go to Weill Cornell Medicine. |
Vol 47 - N° 4
P. 409-414 - avril 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
